Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
EBE-A 22 is an epidermal growth factor receptor inhibitor EGFR, an important target for the treatment of cancer. Selective VEGFR-2 receptor tyrosine kinase inhibitors.
您的位置：
